Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma

ConclusionsLenalidomide appears to be a promising therapeutic agent that offers the possibility of a novel combination of chemotherapy free regimen for patients with B-cell non-Hodgkin lymphoma.
Source: Hormones and Cancer - Category: Cancer & Oncology Source Type: research